This Week in Cardiology cover image

Mar 10 2023 This Week in Cardiology

This Week in Cardiology

00:00

Triluminate Is a Safe Treatment for Heart Failure

The results of triluminate were positive, but a Gina Colada was likely wrong about it being a helpful treatment. The only difference in this trial was a better KCCQ change in the surgery group and KCCQ scores reflect how a patient judges their own well-being. Triluminate is a pre-market approval study and FDA will have to decide on its approval. If they accept these results and approve the device and CMS creates a code for it, I'm afraid there will be a deluge of low-value care," he says.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app